Figures & data
Figure 1 Phase-contrast micrographs of triptolide-treated MCF-7 cells incubated for 24 hours.
![Figure 1 Phase-contrast micrographs of triptolide-treated MCF-7 cells incubated for 24 hours.](/cms/asset/a3668cfe-41be-4bb6-b160-5d448ed0cb7d/djwh_a_44074_f0001_b.jpg)
Figure 2 Effect of triptolide on chromatin condensation.
![Figure 2 Effect of triptolide on chromatin condensation.](/cms/asset/4d720a8c-1e2f-429c-a3fa-12c583b7acad/djwh_a_44074_f0002_c.jpg)
Figure 3 Cell death determination by MTT assay.
Abbreviations: MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; SEM, standard error of the mean.
![Figure 3 Cell death determination by MTT assay.](/cms/asset/1f047074-a780-4f65-9d31-44597cae6b3b/djwh_a_44074_f0003_c.jpg)
Figure 4 Effect of triptolide on pro-apoptotic proteins expression levels.
Abbreviations: PARP, poly(ADP-ribose) polymerase; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis.
![Figure 4 Effect of triptolide on pro-apoptotic proteins expression levels.](/cms/asset/7c9002a2-a1ac-4660-8822-8ea098dc4f47/djwh_a_44074_f0004_b.jpg)
Figure 5 Effect of triptolide on lysosomal enzyme activity.
![Figure 5 Effect of triptolide on lysosomal enzyme activity.](/cms/asset/cb640182-4612-4eca-944a-ca4cfcd96d04/djwh_a_44074_f0005_c.jpg)
Figure 6 Effect of triptolide on localization of lysosomes.
![Figure 6 Effect of triptolide on localization of lysosomes.](/cms/asset/ddd3572e-6010-43cf-bc61-1fb8ddf22404/djwh_a_44074_f0006_c.jpg)
Figure 7 Morphological comparison of lysosomes.
![Figure 7 Morphological comparison of lysosomes.](/cms/asset/7e0e3407-3d07-4bab-a6e5-c9668e9093fe/djwh_a_44074_f0007_c.jpg)
Figure 8 Lysosomal protein expression levels on cytosolic fraction of MCF-7 cells.
![Figure 8 Lysosomal protein expression levels on cytosolic fraction of MCF-7 cells.](/cms/asset/17623f0d-c084-4856-aa27-5e9671dff4b9/djwh_a_44074_f0008_c.jpg)